UK DRI at UCL was selected as the hub of the UK Dementia Research Institute in 2016 because of our strength to bring together excellent clinical and basic neuroscience research to advance understanding of neurodegeneration and identify novel targets and therapeutic approaches for dementia.
Our mission is to play a central and collaborative role in the UK DRI’s efforts to discover and deliver effective therapies. Our mission involves forging effective cross-disciplinary teams and approaches to understand pathogenic mechanisms; developing innovative therapeutic approaches; and providing a translational arm to the UK DRI to harness clinical resources, test and deliver treatments to patients.
People
See more details about our Group Leaders, Emerging Leaders, Lab Members, Professional Services Team and Affiliate Members here
Research
Research at the UK DRI at UCL covers the journey from the person living with dementia to the laboratory and back again - with improved diagnosis and potential therapies put to the test.
Follow us
News
World-leading Alzheimer’s researcher awarded CBE
Professor Bart De Strooper (UK Dementia Research Institute at UCL) has been awarded an honorary CBE for his services to dementia research in the UK and internationally.
21 Oct 2025
Gene therapy appears to slow Huntington’s disease progression
A global clinical trial for a new Huntington’s disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL scientists.
24 Sep 2025
World Alzheimer's Day: Harnessing AI to tackle the global challenge of dementia
Researchers across UCL are applying artificial intelligence in powerful ways to accelerate Alzheimer’s diagnosis, track disease progression and develop new treatments.
19 Sep 2025